Suppr超能文献

[肾盂及输尿管肿瘤手术治疗的长期结果]

[Long-term results of surgical treatment for renal pelvic and ureteral tumors].

作者信息

Yokoyama M, Kano M, Sakai M, Oda H, Inoue K, Kitahara K, Kanemura M, Osada M

机构信息

Department of Urology, Toranomon Hospital.

出版信息

Hinyokika Kiyo. 1995 Oct;41(10):761-6.

PMID:8533670
Abstract

Fifty eight cases of primary tumors in the renal pelvis and ureter were treated at Toranomon Hospital between 1983 and 1992. They consisted of 32 renal pelvic tumors, 21 ureteral tumors and 5 tumors at both sites. The age of the patients ranged from 30 to 84 years (mean 63.1). Surgery was performed in 56 cases. Radical nephroureterectomy with concomitant ipsilateral retroperitoneal lymph node dissection was performed in 38 cases. The other surgeries were radical nephroureterectomy without lymph node dissection in 9, nephrectomy in 4, resection of ureter and reanastomosis in 3, radical nephroureterectomy and cystectomy in 1 and partial nephrectomy in 1. Pathologically, 53 were transitional cell carcinoma (TCC), 2 were TCC plus squamous cell carcinoma and 1 was TCC plus adenocarcinoma. Over-all survival rates (Kaplan-Meier) of 56 surgical cases at 1, 3, 5 years were 92.2, 83.7 and 72.8%, respectively. Combination chemotherapy (M-VAC or CAP) was performed in 9 cases of metastatic disease and 1 case of bilateral disease. Of these 10 cases, one achieved complete remission, 2 no change and 7 had progressive disease. Adjuvant chemotherapy was performed in 21 cases after surgery. These 21 patients were of high risk in recurrence either Grade 3 or pT3. However, the 5-year survival rate was 77.3% in these patients. Thus we conclude that the adjuvant chemotherapy in high risk patients was effective in our cases.

摘要

1983年至1992年间,东京虎之门医院共治疗了58例肾盂和输尿管原发性肿瘤。其中包括32例肾盂肿瘤、21例输尿管肿瘤以及5例同时累及两个部位的肿瘤。患者年龄在30岁至84岁之间(平均63.1岁)。56例患者接受了手术治疗。38例行根治性肾输尿管切除术并同期行同侧腹膜后淋巴结清扫术。其他手术包括9例行根治性肾输尿管切除术但未行淋巴结清扫术、4例行肾切除术、3例行输尿管切除术及再吻合术、1例行根治性肾输尿管切除术及膀胱切除术、1例行部分肾切除术。病理检查显示,53例为移行细胞癌(TCC),2例为TCC合并鳞状细胞癌,1例为TCC合并腺癌。56例手术患者的1年、3年、5年总体生存率(Kaplan-Meier法)分别为92.2%、83.7%和72.8%。9例转移性疾病患者和1例双侧疾病患者接受了联合化疗(M-VAC或CAP)。这10例患者中,1例完全缓解,2例病情无变化,7例病情进展。21例患者术后接受了辅助化疗。这21例患者均为复发高危患者,分级为3级或pT3。然而,这些患者的5年生存率为77.3%。因此,我们得出结论,在我们的病例中,高危患者的辅助化疗是有效的。

相似文献

8
Percutaneous management of renal pelvic urothelial tumors: long-term followup.肾盂尿路上皮肿瘤的经皮治疗:长期随访
J Urol. 2003 Mar;169(3):925-9; discussion 929-30. doi: 10.1097/01.ju.0000050242.68745.4d.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验